Camp4 Therapeutics (CAMP) Financial Statements & Analysis

Camp4 Therapeutics (CAMP) Income Statement

Camp4 Therapeutics reported revenue of $3.50M in fiscal 2025 (fiscal year ended Dec 31, 2025), up 436.5% from $652.00K a year earlier. Camp4 Therapeutics posted a net loss of $80.40M, compared with a net loss of $51.79M a year earlier. Gross margin was 53.1% and operating margin -1488.3%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was $1.78M, up 18.8% from the same quarter a year earlier.

Camp4 Therapeutics Income Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Camp4 Therapeutics Corporation income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Nov 2023	Feb 2023	Dec 2022	Feb 2022	Feb 2021	Feb 2020	Feb 2019	Feb 2018
Revenue & Gross Profit
Revenue	3.50	0.65	0.35	0.35	294.95	-	295.84	308.59	366.11	363.80	365.91
Cost of Revenue	1.64	38.82	40.62	0.00	185.94	34.10	173.95	186.18	222.80	216.04	215.02
Gross Profit	1.86	0.65	0.35	0.35	109.01	-34.10	121.89	122.41	143.30	147.76	150.89
Operating Expenses
Research & Development	38.20	38.82	40.62	40.62	24.57	0.68	28.44	25.81	29.44	27.66	25.76
Selling, General & Administrative	17.36	14.92	11.61	11.61	99.21	10.23	100.90	95.28	118.20	80.96	102.19
Operating Expenses	53.92	53.74	52.23	52.23	133.70	45.00	134.76	125.87	159.96	120.05	142.94
Operating Income	-52.06	-53.09	-51.88	-51.88	-24.69	-45.00	-13.47	-6.83	-16.77	19.70	7.96
Other Income/Expense
Interest Income	2.17	1.33	2.81	2.81	0.99	0.90	0.00	0.00	0.00	0.00	0.00
Interest Expense	0.00	-0.03	-0.03	0.00	6.26	-	5.19	5.82	20.10	16.73	10.28
Other Income/Expense	-28.34	1.30	2.59	2.59	-6.65	0.81	-1.87	-1.64	-41.55	12.87	31.03
Income
Income Before Tax	-80.40	-51.79	-49.29	-49.29	-31.34	-44.19	-30.06	-20.60	-58.32	23.86	28.71
Income Tax Expense	0.00	0.00	-	0.00	1.15	-	1.09	0.56	20.45	-1.33	10.68
Net Income	-80.40	-51.79	-49.29	-49.29	-32.49	-44.19	-27.99	-56.31	-78.77	18.40	16.62
Net Income - Continuous Operations	-80.40	-51.79	-49.29	-49.29	-32.49	-44.19	-27.99	-56.31	-78.77	18.40	16.62
Net Income - Discontinued Operations	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-50.42	-51.39	-50.20	-50.20	-25.08	-44.12	-2.64	8.47	15.22	47.05	31.36
EBIT	-52.06	-53.09	-51.88	-	-	-45.00	-	-	-	-	-
Depreciation & Amortization	1.64	1.70	1.68	1.68	0.00	0.88	22.80	22.00	31.99	20.02	22.96
Earnings Per Share
Basic EPS	-3.00	-11.00	-125.00	-4.00	-1.00	-142.00	-	-	-2.00	1.00	-
Diluted EPS	-3.00	-11.00	-125.00	-4.00	-1.00	-124.00	-	-	-2.00	1.00	-
Basic Shares Outstanding	30.38	4.69	0.39	12.12	36.13	0.31	1.53	1.50	33.48	34.59	35.25
Diluted Shares Outstanding	30.38	4.69	0.39	12.12	36.13	0.31	1.53	1.50	33.67	35.29	36.14

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Camp4 Therapeutics Financial Statements

What was Camp4 Therapeutics's revenue in fiscal 2025?

Camp4 Therapeutics reported revenue of $3.50M in fiscal 2025 (fiscal year ended Dec 31, 2025). That was up 436.5% from $652.00K a year earlier.

Is Camp4 Therapeutics profitable?

No. Camp4 Therapeutics reported a net loss of $80.40M in fiscal 2025. In fiscal 2024 it lost $51.79M.

What is Camp4 Therapeutics's operating margin?

Camp4 Therapeutics's operating income was −$52.06M on revenue of $3.50M in fiscal 2025, an operating margin of -1488.3%, compared with -8142.3% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition